Cuidados especializados de enfermería al niño con influenza
Fuente:
Redalyc
Saved in:
| Main Author: | Diana Xitlalli Rodríguez González |
|---|---|
| Format: | Artículo científico |
| Language: | es |
| Published: |
Universidad Nacional Autónoma de México
2009
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Historia natural de la influenza / Juan Ernesto Ludert
by: Ernesto Ludert, Juan
Published: (2009)
by: Ernesto Ludert, Juan
Published: (2009)
Evolutionary analysis of seasonal influenza A viruses in Pakistan 2020–2023
by: Nazish Badar, et al.
Published: (2024)
by: Nazish Badar, et al.
Published: (2024)
Aspectos clínicos y epidemiológicos de la influenza
by: Carlos Franco-Paredes
Published: (2006)
by: Carlos Franco-Paredes
Published: (2006)
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network
by: Angela M. C. Rose, et al.
Published: (2024)
by: Angela M. C. Rose, et al.
Published: (2024)
Impact of the COVID‐19 related border restrictions on influenza and other common respiratory viral infections in New Zealand
by: Q. Sue Huang, et al.
Published: (2024)
by: Q. Sue Huang, et al.
Published: (2024)
In‐field detection and characterization of B/Victoria lineage deletion variant viruses causing early influenza activity and an outbreak in Louisiana, 2019
by: Bo Shu, et al.
Published: (2024)
by: Bo Shu, et al.
Published: (2024)
Quantified impacts of non‐pharmaceutical interventions on influenza circulation during the COVID‐19 pandemic in 13 African countries, 2020–2022
by: Radhika Gharpure, et al.
Published: (2024)
by: Radhika Gharpure, et al.
Published: (2024)
Role of research Laboratories in pandemic and epidemic response in the Eastern Mediterranean Region: Experiences from COVID‐19, avian influenza, and MERS‐CoV
by: Mona Mahmoud, et al.
Published: (2024)
by: Mona Mahmoud, et al.
Published: (2024)
Genome characterization of influenza A and B viruses in New South Wales, Australia, in 2019: A retrospective study using high‐throughput whole genome sequencing
by: Xinye Wang, et al.
Published: (2024)
by: Xinye Wang, et al.
Published: (2024)
Detection of clade 2.3.4.4 highly pathogenic avian influenza H5 viruses in healthy wild birds in the Hadeji‐Nguru wetland, Nigeria 2022
by: Kayode Olawuyi, et al.
Published: (2024)
by: Kayode Olawuyi, et al.
Published: (2024)
Effect of planned school breaks on student absenteeism due to influenza‐like illness in school aged children—Oregon School District, Wisconsin September 2014–June 2019
by: Cecilia He, et al.
Published: (2024)
by: Cecilia He, et al.
Published: (2024)
SARS‐CoV‐2 Infection Among Nursing Home Healthcare Workers: A Longitudinal Study in North‐Eastern Italy
by: Valentina Rosolen, et al.
Published: (2024)
by: Valentina Rosolen, et al.
Published: (2024)
La enfermería en salud pública: el caso de la Influenza
by: Ezequiel Canela Núñez
Published: (2009)
by: Ezequiel Canela Núñez
Published: (2009)
La influenza, un problema vigente de salud pública
by: Juan García García
Published: (2006)
by: Juan García García
Published: (2006)
Evaluating COVID‐19 Transmission in a Series of Cases and Contacts in Three Municipalities of Colombia: Insights From the WHO First Few X Protocol, August 2020–January 2021
by: Damaris Heredia, et al.
Published: (2026)
by: Damaris Heredia, et al.
Published: (2026)
Letter to the Editor Regarding the Article by Karami et al. on the Surveillance of Endemic Coronaviruses During the COVID‐19 Pandemic in Iran, 2021–2022
by: Eleni Rousogianni, et al.
Published: (2024)
by: Eleni Rousogianni, et al.
Published: (2024)
SARS‐CoV‐2 Viral Load and Cytokine Dynamics Profile as Early Signatures of Long COVID Condition in Hospitalized Individuals
by: Jacobo Alonso Domínguez, et al.
Published: (2025)
by: Jacobo Alonso Domínguez, et al.
Published: (2025)
Nirsevimab Effectiveness Against RSV‐Related Hospitalisations in Children Under 24 Months: A Test‐Negative Case–Control Study in Portugal, 2024–2025
by: Vânia Gaio, et al.
Published: (2025)
by: Vânia Gaio, et al.
Published: (2025)
Relevance of comorbidities for main outcomes during different periods of the COVID‐19 pandemic
by: José M. Quintana‐Lopez, et al.
Published: (2024)
by: José M. Quintana‐Lopez, et al.
Published: (2024)
Shifts in Respiratory Virus Epidemiology on Reunion Island From 2017 to 2023: Impact of COVID‐19 Pandemic and Non‐Pharmaceutical Interventions
by: Nicolas M'nemosyme, et al.
Published: (2025)
by: Nicolas M'nemosyme, et al.
Published: (2025)
Correspondence About the Paper “Effectiveness of High‐Dose Influenza Vaccine Against Hospitalisations in Older Adults (FLUNITY‐HD): An Individual Level Pooled Analysis” by Niklas Dyrby Johansen et al., https://doi.org/10.1016/S0140‐6736(25)01742‐8
by: Miloš Jeseňák, et al.
Published: (2026)
by: Miloš Jeseňák, et al.
Published: (2026)
Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain
by: Clara Mazagatos, et al.
Published: (2024)
by: Clara Mazagatos, et al.
Published: (2024)
Genomic Insights Into Respiratory Syncytial Virus Circulation Patterns and Neutralization by Anti‐F Monoclonal Antibodies in Panama (2018–2024)
by: Danilo Franco, et al.
Published: (2025)
by: Danilo Franco, et al.
Published: (2025)
WHO's Investigations and Studies, Unity Studies: A global initiative creating equitable opportunities for enhanced surveillance, operational research, capacity building, and global knowledge sharing
by: Isabel Bergeri, et al.
Published: (2024)
by: Isabel Bergeri, et al.
Published: (2024)
Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019–2020 Season in Philadelphia, Pennsylvania
by: Lydia M. Mendoza, et al.
Published: (2025)
by: Lydia M. Mendoza, et al.
Published: (2025)
Evaluating Bacillus Calmette–Guérin Polysaccharide Nucleic Acid as an Adjuvant for Influenza Vaccines in Mice
by: Sijing Yan, et al.
Published: (2025)
by: Sijing Yan, et al.
Published: (2025)
Effectiveness of the XBB.1.5 COVID‐19 Vaccines Against SARS‐CoV‐2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024
by: Liliana Antunes, et al.
Published: (2025)
by: Liliana Antunes, et al.
Published: (2025)
Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024
by: Lore Merdrignac, et al.
Published: (2024)
by: Lore Merdrignac, et al.
Published: (2024)
Neurologic Complications of Influenza and Potential Protective Vaccine Effects
by: Ann R. Falsey
Published: (2025)
by: Ann R. Falsey
Published: (2025)
Age‐Related Asymptomatic Rhinovirus Infections Contribute to the Sustained Prevalence in Adults and Are Not Mitigated by Nonpharmaceutical Interventions
by: Dong Wei, et al.
Published: (2026)
by: Dong Wei, et al.
Published: (2026)
Expanded Genomic Surveillance and Seasonal Comparisons of Human Respiratory Syncytial Virus Infections in Minnesota, USA, 2023–2025
by: Daniel Evans, et al.
Published: (2026)
by: Daniel Evans, et al.
Published: (2026)
High Infection Risk Among Health Care Workers During the First SARS‐CoV‐2 Wave in Niamey, Niger
by: Hamidou Lazoumar Ramatoulaye, et al.
Published: (2025)
by: Hamidou Lazoumar Ramatoulaye, et al.
Published: (2025)
Cardiac Characteristics of Hospitalized Influenza Patients: An Interim Analysis From the FluHeart Study
by: Kristoffer Grundtvig Skaarup, et al.
Published: (2025)
by: Kristoffer Grundtvig Skaarup, et al.
Published: (2025)
Incidence of Hospitalization due to Influenza‐Associated Severe Acute Respiratory Infection During 2010–2019 in Bangladesh
by: Mohammad Abdul Aleem, et al.
Published: (2024)
by: Mohammad Abdul Aleem, et al.
Published: (2024)
Changes in the Epidemiology of Influenza and Respiratory Syncytial Virus During 2020–2022 Relative to the Pre‐COVID‐19 Pandemic Period (2017–2020) From Systematic Sentinel Syndromic Surveillance in South Africa
by: Sibongile Walaza, et al.
Published: (2026)
by: Sibongile Walaza, et al.
Published: (2026)
Longitudinal SARS‐CoV‐2 Antibody Response in Healthcare Workers: Benefit of Prior Infection and Heterologous Boosting on Anti‐Spike IgG Immunity
by: Els Van Nedervelde, et al.
Published: (2026)
by: Els Van Nedervelde, et al.
Published: (2026)
Issue Information
Published: (2025)
Published: (2025)
Influenza Epidemiology in Finland During and After the COVID‐19 Pandemic: Surveillance Data Analysis (2019–2024)
by: Ulrike Baum, et al.
Published: (2025)
by: Ulrike Baum, et al.
Published: (2025)
Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024–2025 Winter Season
by: Daniel Aguilar Figueroa, et al.
Published: (2025)
by: Daniel Aguilar Figueroa, et al.
Published: (2025)
Adverse Effects Related to Paediatric Influenza Vaccination and Its Influence on Vaccination Acceptability. The FLUTETRA Study: A Survey Conducted in the Region of Murcia, Spain
by: Matilde Zornoza Moreno, et al.
Published: (2024)
by: Matilde Zornoza Moreno, et al.
Published: (2024)
Similar Items
-
Historia natural de la influenza / Juan Ernesto Ludert
by: Ernesto Ludert, Juan
Published: (2009) -
Evolutionary analysis of seasonal influenza A viruses in Pakistan 2020–2023
by: Nazish Badar, et al.
Published: (2024) -
Aspectos clínicos y epidemiológicos de la influenza
by: Carlos Franco-Paredes
Published: (2006) -
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network
by: Angela M. C. Rose, et al.
Published: (2024) -
Impact of the COVID‐19 related border restrictions on influenza and other common respiratory viral infections in New Zealand
by: Q. Sue Huang, et al.
Published: (2024)